The Effect of a Combined Intermittent Fasting Healthy Plate Intervention on Anthropometric Outcomes and Body Composition Among Adults With Overweight and Obesity: Nonrandomized Controlled Trial (Preprint)

Abstract

Adult obesity and overweight pose a substantial risk to global public health and are associated with various noncommunicable diseases. Although intermittent fasting (IF) is increasingly used as a relatively new dietary strategy for weight loss, the effectiveness of 2 days per week of dry fasting remains unknown.

This study aims to evaluate the effectiveness of a combined dry IF and healthy plate (IFHP) and healthy plate (HP) intervention in improving anthropometric outcomes and body composition.

This nonrandomized controlled trial involved 177 adults who were overweight and obese. Among them, 91 (51.4%) were allocated to the IFHP group and 86 (48.6%) were allocated to the HP group. The overall study duration was 6 months (October 2020 to March 2021). The intervention was divided into 2 phases: supervised (3 months) and unsupervised (3 months). The data were collected at baseline, after the supervised phase (month 3), and after the unsupervised phase (month 6). Anthropometric (weight, height, waist circumference, and hip circumference) and body composition (body fat percentage, body fat mass, skeletal muscle mass, and visceral fat area) data were measured at all 3 data collection points. Sociodemographic data were obtained using a questionnaire at baseline.

Most participants were female (147/177, 83.1%) and Malay (141/177, 79.7%). After 3 months, there were significant reductions in weight (difference −1.68; <i>P</i>&lt;.001), BMI (difference −0.62; <i>P</i>&lt;.001), body fat percentage (difference −0.921; <i>P</i>&lt;.001), body fat mass (difference −1.28; <i>P</i>&lt;.001), and visceral fat area (difference −4.227; <i>P</i>=.008) in the IFHP group, whereas no significant changes were observed in the HP group. Compared to baseline, participants in the IFHP group showed a significant decrease in weight (difference −1.428; <i>P</i>=.003), BMI (difference −0.522; <i>P</i>=.005), body fat percentage (difference −1.591; <i>P</i>&lt;.001), body fat mass (difference −1.501; <i>P</i>&lt;.001), visceral fat area (difference −7.130; <i>P</i>&lt;.001), waist circumference (difference −2.304; <i>P</i>=.001), and hip circumference (difference −1.908; <i>P</i>=.002) at month 6. During the unsupervised phase, waist (IFHP difference −3.206; <i>P</i>&lt;.001, HP difference −2.675; <i>P</i>=.004) and hip (IFHP difference −2.443; <i>P</i>&lt;.001; HP difference −2.896; <i>P</i>&lt;.001) circumferences were significantly reduced in both groups (<i>P</i>&lt;.01), whereas skeletal muscle mass (difference 0.208; <i>P</i>=.04) and visceral fat area (difference −2.903; <i>P</i>=.003) were significantly improved in the IFHP group only. No significant difference in the between-group comparison was detected throughout the intervention (all <i>P</i>&gt;.05).

A combined IFHP intervention was effective in improving anthropometric outcomes and body composition in adults with overweight and obesity.

RR2-10.2196/33801.